Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Lithium for Behavioral Symptoms in FTD
NCT02862210Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jan 2017
- Primary completion
- Nov 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in frontotemporal dementia (FTD), sponsored by Columbia University. Started Jan 2017; status: completed.
02
Drugs
lithium carbonate
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT02862210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862210.